作者:Dun Wang、Like Hou、Lirong Wu、Xin Yu
DOI:10.1248/cpb.60.513
日期:——
The design, synthesis and biological evaluation of a novel series of oxazinyl isoflavonoids is described. Several analogs were shown to exhibit growth inhibitory effects against SKOV-3, DU-145 and HL-60 human colon cancer cell lines with IC50 values in the micromolar range. The cellular potency of compounds 7e and 12h were found to have greater in vitro inhibitory activities than phenoxodiol, the parental compound currently in late-stage clinical trials for the treatment of cancer. The results shown are suitable for further lead optimization.
本文介绍了一系列新型噁嗪基异黄酮的设计、合成和生物学评价。研究表明,几种类似物对 SKOV-3、DU-145 和 HL-60 人类结肠癌细胞系具有生长抑制作用,其 IC50 值在微摩尔范围内。研究发现,化合物 7e 和 12h 的体外抑制活性高于苯麝香二醇(目前正处于治疗癌症的后期临床试验阶段的母体化合物)。所显示的结果适于进一步优化先导化合物。